Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders (original) (raw)

References

1. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402–409
   Article CAS PubMed Google Scholar
2. Anholt RR, Pedersen PL, De Souza EB, Snyder SH (1986) The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 261:576–583
   CAS PubMed Google Scholar
3. Joseph-Liauzun E, Delmas P, Shire D, Ferrara P (1998) Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-transmembrane structure. J Biol Chem 273:2146–2152
   Article CAS PubMed Google Scholar
4. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH (1992) Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci USA 89:3170–3174
   Article CAS PubMed PubMed Central Google Scholar
5. Garnier M, Dimchev AB, Boujrad N, Price JM, Musto NA, Papadopoulos V (1994) In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells. Mol Pharmacol 45:201–211
   CAS PubMed Google Scholar
6. Veenman L, Shandalov Y, Gavish M (2008) VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J Bioenerg Biomembr 40:199–205
   Article CAS PubMed Google Scholar
7. Lacapere JJ, Papadopoulos V (2003) Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 68:569–585
   Article CAS PubMed Google Scholar
8. Casellas P, Galiegue S, Basile AS (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40:475–486
   Article CAS PubMed Google Scholar
9. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51:629–650
   CAS PubMed Google Scholar
10. Kuhlmann AC, Guilarte TR (2000) Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem 74:1694–1704
    Article CAS PubMed Google Scholar
11. Maeda J, Higuchi M, Inaji M, Ji B, Haneda E, Okauchi T, Zhang MR, Suzuki K, Suhara T (2007) Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res 1157:100–111
    Article CAS PubMed Google Scholar
12. Hirsch JD, Beyer CF, Malkowitz L, Beer B, Blume AJ (1989) Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol Pharmacol 35:157–163
    CAS PubMed Google Scholar
13. Corsi L, Geminiani E, Baraldi M (2008) Peripheral benzodiazepine receptor (PBR) new insight in cell proliferation and cell differentiation review. Curr Clin Pharmacol 3:38–45
    Article CAS PubMed Google Scholar
14. Veenman L, Papadopoulos V, Gavish M (2007) Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 13:2385–2405
    Article CAS PubMed Google Scholar
15. Besman MJ, Yanagibashi K, Lee TD, Kawamura M, Hall PF, Shively JE (1989) Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad Sci USA 86:4897–4901
    Article CAS PubMed PubMed Central Google Scholar
16. Rupprecht R, Holsboer F (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22:410–416
    Article CAS PubMed Google Scholar
17. Stoffel-Wagner B (2001) Neurosteroid metabolism in the human brain. Eur J Endocrinol 145:669–679
    Article CAS PubMed Google Scholar
18. Papadopoulos V, Liu J, Culty M (2007) Is there a mitochondrial signaling complex facilitating cholesterol import? Mol Cell Endocrinol 265–266:59–64
    Article PubMed Google Scholar
19. Melcangi RC, Celotti F, Martini L (1994) Progesterone 5-alpha-reduction in neuronal and in different types of glial cell cultures: type 1 and 2 astrocytes and oligodendrocytes. Brain Res 639:202–206
    Article CAS PubMed Google Scholar
20. Melcangi RC, Poletti A, Cavarretta I, Celotti F, Colciago A, Magnaghi V, Motta M, Negri-Cesi P, Martini L (1998) The 5 alpha-reductase in the central nervous system: expression and modes of control. J Steroid Biochem Mol Biol 65:295–299
    Article CAS PubMed Google Scholar
21. Tsuruo Y (2005) Topography and function of androgen-metabolizing enzymes in the central nervous system. Anat Sci Int 80:1–11
    Article CAS PubMed Google Scholar
22. Agis-Balboa RC, Pinna G, Zhubi A, Maloku E, Veldic M, Costa E, Guidotti A (2006) Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci USA 103:14602–14607
    Article CAS PubMed PubMed Central Google Scholar
23. Nakamura K, Fukunishi I, Nakamoto Y, Iwahashi K, Yoshii M (2002) Peripheral-type benzodiazepine receptors on platelets are correlated with the degrees of anxiety in normal human subjects. Psychopharmcol 162:301–303
    Article CAS Google Scholar
24. Nudmamud S, Siripurkpong P, Chindaduangratana C, Harnyuttanakorn P, Lotrakul P, Laarbboonsarp W, Srikiatkhachorn A, Kotchabhakdi N, Casalotti S (2000) Stress, anxiety and peripheral benzodiazepine receptor mRNA levels in human lymphocytes. Life Sci 67:2221–2231
    Article CAS PubMed Google Scholar
25. Rocca P, Beoni AM, Eva C, Ferrero P, Zanalda E, Ravizza P (1998) Peripheral benzodiazepine receptor messenger RNA is decreased in lymphocytes of generalized anxiety disorder patients. Biol Psychiatry 43:767–773
    Article CAS PubMed Google Scholar
26. Johnson MR, Marazziti D, Brawman-Mintzer O, Emmanuel NP, Ware MR, Morton WA, Rossi A, Cassano GB, Lydiard RB (1998) Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry 43:306–309
    Article CAS PubMed Google Scholar
27. Gavish M, Laor N, Bidder M, Fisher D, Fonia O, Muller U, Reiss A, Wolmer L, Karp L, Weizman R (1996) Altered platelet peripheral-type benzodiazepine receptor in posttraumatic stress disorder. Neuropsychopharmacology 14:181–186
    Article CAS PubMed Google Scholar
28. Pini S, Martini C, Abelli M, Muti M, Gesi C, Montali M, Cassano GB (2005) Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptoms. Psychopharmcol 181:407–411
    Article CAS Google Scholar
29. Ritsner M, Modai I, Gibel A, Leschiner S, Silver H, Tsinovoy G, Weizman A, Gavish M (2003) Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients. J Psychiatr Res 37:549–556
    Article PubMed Google Scholar
30. Mohler H (2006) GABA(A) receptor diversity and pharmacology. Cell Tissue Res 326:505–516
    Article CAS PubMed Google Scholar
31. Uusi-Oukari M, Korpi ER (2010) Regulation of GABA(A) receptor subunit expression by pharmacological agents. Pharmacol Rev 62:97–135
    Article CAS PubMed Google Scholar
32. Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Allgulander C et al (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders—first revision. World J Biol Psychiatry 9:248–312
    Article PubMed Google Scholar
33. Sheehan DV (2002) The management of panic disorder. J Clin Psychiatry 63(Suppl 14):17–21
    CAS PubMed Google Scholar
34. Eser D, Baghai TC, Schule C, Nothdurfter C, Rupprecht R (2008) Neuroactive steroids as endogenous modulators of anxiety. Curr Pharm Des 14:3525–3533
    Article CAS PubMed Google Scholar
35. Rupprecht R (2003) Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinol 28:139–168
    Article CAS Google Scholar
36. Li H, Papadopoulos V (1998) Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139:4991–4997
    CAS PubMed Google Scholar
37. Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V (2001) Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci USA 98:1267–1272
    Article CAS PubMed PubMed Central Google Scholar
38. Anzini M, Cappelli A, Vomero S, Seeber M, Menziani MC, Langer T, Hagen B, Manzoni C, Bourguignon JJ (2001) Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling. J Med Chem 44:1134–1150
    Article CAS PubMed Google Scholar
39. Farges R, Joseph-Liauzun E, Shire D, Caput D, Le FG, Ferrara P (1994) Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864. Mol Pharmacol 46:1160–1167
    CAS PubMed Google Scholar
40. Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9:971–988
    Article CAS PubMed Google Scholar
41. Chauveau F, Boutin H, Van CN, Dolle F, Tavitian B (2008) Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging 35:2304–2319
    Article PubMed Google Scholar
42. Nguyen N, Fakra E, Pradel V, Jouve E, Alquier C, Le Guern M, Micallef J, Blin O (2006) Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. Hum Psychopharmacol 21:139–149
    Article CAS PubMed Google Scholar
43. Schlichter R, Rybalchenko V, Poisbeau P, Verleye M, Gillardin J (2000) Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine. Neuropharmacology 39:1523–1535
    Article CAS PubMed Google Scholar
44. Verleye M, Akwa Y, Liere P, Ladurelle N, Pianos A, Eychenne B, Schumacher M, Gillardin JM (2005) The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. Pharmacol Biochem Behav 82:712–720
    Article CAS PubMed Google Scholar
45. Kita A, Kinoshita T, Kohayakawa H, Furukawa K, Akaike A (2009) Lack of tolerance to anxiolysis and withdrawal symptoms in mice repeatedly treated with AC-5216, a selective TSPO ligand. Prog Neuropsychopharmacol Biol Psychiatry 33:1040–1045
    Article CAS PubMed Google Scholar
46. Rupprecht R, Rammes G, Eser D, Baghai TC, Schule C, Nothdurfter C, Troxler T, Gentsch C, Kalkman HO, Chaperon F, Uzunov V, McAllister KH, Bertaina-Anglade V, La Rochelle CD, Tuerck D, Floesser A, Kiese B, Schumacher M, Landgraf R, Holsboer F, Kucher K (2009) Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325:490–493
    Article CAS PubMed Google Scholar
47. Karchewski LA, Bloechlinger S, Woolf CJ (2004) Axonal injury-dependent induction of the peripheral benzodiazepine receptor in small-diameter adult rat primary sensory neurons. Eur J Neurosci 20:671–683
    Article PubMed Google Scholar
48. Mills CD, Bitler JL, Woolf CJ (2005) Role of the peripheral benzodiazepine receptor in sensory neuron regeneration. Mol Cell Neurosci 30:228–237
    Article CAS PubMed Google Scholar
49. Lacor P, Gandolfo P, Tonon MC, Brault E, Dalibert I, Schumacher M, Benavides J, Ferzaz B (1999) Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis. Brain Res 815:70–80
    Article CAS PubMed Google Scholar
50. Ferzaz B, Brault E, Bourliaud G, Robert JP, Poughon G, Claustre Y, Marguet F, Liere P, Schumacher M, Nowicki JP, Fournier J, Marabout B, Sevrin M, George P, Soubrie P, Benavides J, Scatton B (2002) SSR180575 (7-chloro-N, N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1 -acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair. J Pharmacol Exp Ther 301:1067–1078
    Article CAS PubMed Google Scholar
51. Bordet T, Buisson B, Michaud M, Abitbol JL, Marchand F, Grist J, Andriambeloson E, Malcangio M, Pruss RM (2008) Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. J Pharmacol Exp Ther 326:623–632
    Article CAS PubMed Google Scholar
52. Giatti S, Pesaresi M, Cavaletti G, Bianchi R, Carozzi V, Lombardi R, Maschi O, Lauria G, Garcia-Segura LM, Caruso D, Melcangi RC (2009) Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience 164:520–529
    Article CAS PubMed Google Scholar
53. Girard C, Liu S, Cadepond F, Adams D, Lacroix C, Verleye M, Gillardin JM, Baulieu EE, Schumacher M, Schweizer-Groyer G (2008) Etifoxine improves peripheral nerve regeneration and functional recovery. Proc Natl Acad Sci USA 105:20505–20510
    Article CAS PubMed PubMed Central Google Scholar
54. Papadopoulos V, Lecanu L (2009) Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma. Exp Neurol 219:53–57
    Article CAS PubMed PubMed Central Google Scholar
55. Kunduzova OR, Escourrou G, De La Farge F, Salvayre R, Seguelas MH, Leducq N, Bono F, Herbert JM, Parini A (2004) Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion. J Am Soc Nephrol 15:2152–2160
    Article CAS PubMed Google Scholar
56. Ji B, Maeda J, Sawada M, Ono M, Okauchi T, Inaji M, Zhang MR, Suzuki K, Ando K, Staufenbiel M, Trojanowski JQ, Lee VM, Higuchi M, Suhara T (2008) Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer’s and other CNS pathologies. J Neurosci 28:12255–12267
    Article CAS PubMed PubMed Central Google Scholar

Download references